Duopharma Biotech Bhd (7148) — Strategic Asset Allocation Index
Duopharma Biotech Bhd (7148) has a Strategic Asset Allocation Index of 73.1% as of December 2025. Strategic assets (PP&E of RM554.08 Million plus long-term investments of RM-) total RM554.08 Million, measured against net assets of RM757.62 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Duopharma Biotech Bhd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Duopharma Biotech Bhd Strategic Asset Allocation Index (2016–2024)
This chart shows how Duopharma Biotech Bhd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of December 2025, the index stands at 73.1%, representing strategic assets of RM554.08 Million against net assets of RM757.62 Million MYR. For live market cap and overall valuation, see Duopharma Biotech Bhd (7148) total market value.
Annual Strategic Asset Allocation Index for Duopharma Biotech Bhd (2016–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Duopharma Biotech Bhd from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 7148 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (MYR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.0% | RM567.52 Million | RM567.52 Million | RM- | RM709.15 Million | ▼ -4.7 pp |
| 2023 | 84.8% | RM582.37 Million | RM582.37 Million | RM- | RM687.12 Million | ▼ -3.8 pp |
| 2022 | 88.5% | RM579.92 Million | RM579.92 Million | RM- | RM655.22 Million | ▲ +1.4 pp |
| 2021 | 87.1% | RM543.44 Million | RM543.44 Million | RM- | RM624.00 Million | ▲ +18.5 pp |
| 2020 | 68.6% | RM441.79 Million | RM441.79 Million | RM- | RM643.82 Million | ▼ -9.2 pp |
| 2019 | 77.8% | RM412.25 Million | RM412.25 Million | RM- | RM529.75 Million | ▼ -2.5 pp |
| 2018 | 80.3% | RM386.18 Million | RM386.18 Million | RM- | RM481.04 Million | ▲ +13.3 pp |
| 2017 | 67.0% | RM321.33 Million | RM321.33 Million | RM- | RM479.87 Million | ▲ +6.2 pp |
| 2016 | 60.8% | RM276.24 Million | RM276.24 Million | RM- | RM454.52 Million | — |